|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 9/50 | (2006.01) |
| A61K 31/57 | (2006.01) |
| (11) | Number of the document | 2978414 |
| (13) | Kind of document | T |
| (96) | European patent application number | 14727028.4 |
| Date of filing the European patent application | 2014-05-12 | |
| (97) | Date of publication of the European application | 2016-02-03 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-22 |
| (46) | Date of publication of the claims translation | 2020-09-25 |
| (86) | Number | PCT/GB2014/051442 |
| Date | 2014-05-12 |
| (87) | Number | WO 2014/184525 |
| Date | 2014-11-20 |
| (30) | Number | Date | Country code |
| 201308933 | 2013-05-17 | GB |
| (72) |
HUATAN, Hiep, GB
ROSS, Richard, GB
WHITAKER, Martin, GB
POELLINGER, Norbert, DE
GRAVE, Annette, DE
|
| (73) |
Neurocrine UK Limited,
Cardiff Medicentre Heath Park, Cardiff, Glamorgan CF14 4UJ,
GB
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Kompozicija, apimanti hidrokortizoną |
| COMPOSITION COMPRISING HYDROCORTISONE |
| Payment date | Validity (years) | Amount | |
| 2025-04-22 | 12 | 289.00 EUR |
| 2026-05-12 |